Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-11.83	46.32	52.54
Graham Fair Price	-71.66	1.72	6.07
PEG	15811.61	1.57	< 0.005
Price/Book	21.42	3.66	3.01
Price/Cash Flow	10.69	33.70	30.44
Prices/Earnings	1303.67	-170.40	12.14
Price/Sales	23.50	4.63	3.75
Price/FCF	10.69	33.70	30.44
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.79	0.59	0.58
Operating Margin	2.19	0.09	0.09
ROA	-91.52	< 0.005	0.02
ROE	0.06	< 0.005	-91.35
ROIC	0.03	0.04	14.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	0.03	-64.72
Dividends QOQ	< 0.005	< 0.005	44.21
EBIT QOQ	3.34	-0.03	-99.11
EPS QOQ	12.28	-1.08	-91.18
FCF QOQ	10.55	0.06	-99.44
Revenue QOQ	0.09	-0.05	-41.77
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	167.64	161.42	-3.71
Days Sales Outstanding (DSO)	41.25	38.19	-7.42
Inventory Turnover	0.54	0.56	3.85
Debt/Capitalization	0.52	0.39	-24.67
Quick Ratio	0.64	0.67	3.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.14	4.95	-3.65
Cash	1.00	1.30	29.28
Capex	-0.14	-0.18	-26.45
Free Cash Flow	0.51	0.54	5.69
Revenue	4.13	3.91	-5.27
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.48	1.43	-3.35
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.78	8.56	-27.38
Naive Interpretation	Member

06 - Financial Health · Weak

Rating